Do sucralfate and famotidine interfere with the Helicobacter pylori urea breath test?

H2-Receptor Antagonists and Sucralfate Interference with H. pylori Breath Testing

Famotidine (an H2-receptor antagonist) can cause false-negative urea breath test results, though to a much lesser extent than proton pump inhibitors, while sucralfate can also produce false-negative results even after a single day of therapy. 1, 2

Famotidine (H2-Receptor Antagonist) Effects

Evidence of Interference

• H2-receptor antagonists may lead to some false-negative UBT results, but to a much lesser extent than PPIs, and the Maastricht IV consensus panel did not find it necessary to routinely stop them before testing when using citric acid test meals. 1

• However, research demonstrates that famotidine can reduce UBT values by approximately 50-63% when combined with bicarbonate test meals, with about 10% of patients becoming falsely negative. 3

• The mechanism differs from PPIs: high intragastric pH from H2-receptor antagonists may cause a reduction in urease activity that is unrelated to reduced bacterial load and can be reversed with citric acid. 3

• One study found that 1 of 15 patients (7%) given roxatidine showed false-negative UBT results, while no false-negatives occurred with famotidine in that particular cohort. 4

Clinical Implications

• The risk of false-negative results with H2-receptor antagonists appears dependent on the test meal composition - citric acid test meals may overcome the pH-related interference. 1, 3

• If a negative UBT is obtained while a patient is on famotidine, repeat testing after stopping the medication for at least 2 weeks is prudent to confirm true negativity. 1

• The standard recommendation is to stop H2-receptor antagonists for 2 weeks before testing, though this is less critical than with PPIs. 1

Sucralfate Effects

Evidence of Interference

• Even a single day of sucralfate therapy (5 g) can result in false-negative UBT results. 2

• Sucralfate is classified among drugs that can temporarily decrease bacterial load in the stomach, leading to false-negative results on rapid urease tests, culture, histology, UBT, and stool antigen tests. 1

• The mechanism appears to be related to sucralfate's direct effects on H. pylori colonization and the gastric mucosal environment, as it has been shown to reduce H. pylori colonization rates (from 91.67% to 50% in animal models). 5

Clinical Implications

• Sucralfate should be stopped for at least 2 weeks before performing a UBT to reduce the risk of false-negative results. 1

• If testing cannot be delayed, a positive result can still be trusted, as these medications do not produce false-positive tests. 1

Practical Testing Algorithm

When patients are on famotidine or sucralfate:

1. Ideally, discontinue both medications for 2 weeks before UBT testing. 1

2. If testing cannot be delayed and the UBT is positive, the result is reliable and treatment can proceed. 1

3. If testing cannot be delayed and the UBT is negative, repeat the test at least 2 weeks after stopping these medications to confirm true negativity before excluding H. pylori infection. 1

4. Alternative: Use validated IgG serology if medications cannot be stopped, as serology is the only test unaffected by medications that reduce bacterial load. 1

5. For UBT during medication use, ensure citric acid test meals are used rather than bicarbonate-based meals, as this may reduce false-negative rates with H2-receptor antagonists. 1, 3

Important Caveats

• The interference from both medications is less pronounced than with PPIs (which cause 10-40% false-negative rates), but still clinically significant. 1

• Antibiotics and bismuth products cause similar interference and should also be stopped for 2 weeks before testing. 1

• In patients with peptic ulcer bleeding requiring acid suppression, perform UBT as early as possible after resuming oral feeding to minimize the duration of medication interference. 6